Hepatitis Monthly

Published by: Kowsar

HCV NS3 Blocking Effect on IFN Induced ISGs Like Viperin and IL28 With and Without NS4A

Zahra Khanlari 1 , Farzaneh Sabahi 1 , * , Seyed Younes Hosseini 2 and Mostafa Ghaderi 1
Authors Information
1 Department of Medical Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
2 Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Hepatitis Monthly: June 01, 2014, 14 (6); e17822
  • Published Online: June 8, 2014
  • Article Type: Research Article
  • Received: January 25, 2014
  • Revised: March 9, 2014
  • Accepted: April 13, 2014
  • DOI: 10.5812/hepatmon.17822

To Cite: Khanlari Z, Sabahi F, Hosseini S Y, Ghaderi M. HCV NS3 Blocking Effect on IFN Induced ISGs Like Viperin and IL28 With and Without NS4A, Hepat Mon. 2014 ; 14(6):e17822. doi: 10.5812/hepatmon.17822.

Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989; 244(4902): 359-62[PubMed]
  • 2. Raney KD, Sharma SD, Moustafa IM, Cameron CE. Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target. J Biol Chem. 2010; 285(30): 22725-31[DOI][PubMed]
  • 3. World Health Organization . . Media Centre,Hepatitis C. 2012;
  • 4. Freundt EC, Lenardo MJ. Interfering with interferons: Hepatitis C virus counters innate immunity. Proc Natl Acad Sci U S A. 2005; 102(49): 17539-40[DOI][PubMed]
  • 5. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology. 1992; 16(2): 293-9[PubMed]
  • 6. Short J. Viral evasion of interferon stimulated geneg. Bioscience Horizone. 2009; 2(2): 212-24[DOI]
  • 7. Fitzgerald KA. The interferon inducible gene: Viperin. J Interferon Cytokine Res. 2011; 31(1): 131-5[DOI][PubMed]
  • 8. Mattijssen S, Pruijn GJ. Viperin, a key player in the antiviral response. Microbes Infect. 2012; 14(5): 419-26[DOI][PubMed]
  • 9. Seo JY, Yaneva R, Cresswell P. Viperin: a multifunctional, interferon-inducible protein that regulates virus replication. Cell Host Microbe. 2011; 10(6): 534-9[DOI][PubMed]
  • 10. Chan YL, Chang TH, Liao CL, Lin YL. The cellular antiviral protein viperin is attenuated by proteasome-mediated protein degradation in Japanese encephalitis virus-infected cells. J Virol. 2008; 82(21): 10455-64[DOI][PubMed]
  • 11. White LK, Sali T, Alvarado D, Gatti E, Pierre P, Streblow D, et al. Chikungunya virus induces IPS-1-dependent innate immune activation and protein kinase R-independent translational shutoff. J Virol. 2011; 85(1): 606-20[DOI][PubMed]
  • 12. Khaiboullina SF, Rizvanov AA, Holbrook MR, St Jeor S. Yellow fever virus strains Asibi and 17D-204 infect human umbilical cord endothelial cells and induce novel changes in gene expression. Virology. 2005; 342(2): 167-76[DOI][PubMed]
  • 13. Helbig KJ, Lau DT, Semendric L, Harley HA, Beard MR. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology. 2005; 42(3): 702-10[DOI][PubMed]
  • 14. Wang S, Wu X, Pan T, Song W, Wang Y, Zhang F, et al. Viperin inhibits hepatitis C virus replication by interfering with binding of NS5A to host protein hVAP-33. J Gen Virol. 2012; 93: 83-92[DOI][PubMed]
  • 15. Jouan L, Melancon P, Rodrigue-Gervais IG, Raymond VA, Selliah S, Boucher G, et al. Distinct antiviral signaling pathways in primary human hepatocytes and their differential disruption by HCV NS3 protease. J Hepatol. 2010; 52(2): 167-75[DOI][PubMed]
  • 16. Romano KP, Laine JM, Deveau LM, Cao H, Massi F, Schiffer CA. Molecular mechanisms of viral and host cell substrate recognition by hepatitis C virus NS3/4A protease. J Virol. 2011; 85(13): 6106-16[DOI][PubMed]
  • 17. Tomei L, Failla C, Santolini E, De Francesco R, La Monica N. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol. 1993; 67(7): 4017-26[PubMed]
  • 18. Hosseini SY, Sabahi F, Moazzeni SM, Modarressi MH, Saberi Firoozi M, Ravanshad M. Construction and preparation of three recombinant adenoviruses expressing truncated NS3 and core genes of hepatitis C virus for vaccine purposes. Hepat Mon. 2012; 12(8)[DOI][PubMed]
  • 19. Conceicao TM, El-Bacha T, Villas-Boas CS, Coello G, Ramirez J, Montero-Lomeli M, et al. Gene expression analysis during dengue virus infection in HepG2 cells reveals virus control of innate immune response. J Infect. 2010; 60(1): 65-75[DOI][PubMed]
  • 20. Berenguer M, López-Labrador FX. Boceprevir in the treatment of chronic hepatitis C virus infection. Virus Adaptation and Treatment. 2011; 3: 7-17
  • 21. Dubuisson J, Penin F, Moradpour D. Interaction of hepatitis C virus proteins with host cell membranes and lipids. Trends Cell Biol. 2002; 12(11): 517-23[PubMed]
  • 22. Der SD, Zhou A, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A. 1998; 95(26): 15623-8[PubMed]
  • 23. Helbig KJ, Eyre NS, Yip E, Narayana S, Li K, Fiches G, et al. The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A. Hepatology. 2011; 54(5): 1506-17[DOI][PubMed]
  • 24. Jiang D, Guo H, Xu C, Chang J, Gu B, Wang L, et al. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J Virol. 2008; 82(4): 1665-78[DOI][PubMed]
  • 25. Eisa ZM. Effect of protease and helicase mutations on HCV NS3 activity. Saudi J Biol Sci. 2011; 18(2): 195-200[DOI][PubMed]
  • 26. Heim MH, Moradpour D, Blum HE. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J Virol. 1999; 73(10): 8469-75[PubMed]
  • 27. Kaukinen P, Sillanpaa M, Kotenko S, Lin R, Hiscott J, Melen K, et al. Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression. Virol J. 2006; 3: 66[DOI][PubMed]
  • 28. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A. 2005; 102(8): 2992-7[DOI][PubMed]
  • 29. Ochi H, Maekawa T, Abe H, Hayashida Y, Nakano R, Imamura M, et al. IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations. J Gen Virol. 2011; 92: 1071-81[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments